Systemic mastocytosis with an associated hematologic clonal, non-mast cell lineage disease ... bone marrow, spleen, and GI tract. Cutaneous mast cell-like lesions are frequently absent.

The focus of the presentation will be on the subgroup of patients who have received 100mg bezuclastinib for at least 48 weeks to highlight the symptomatic benefits of long-term use.